Thomas Aparicio
Université Paris Cité(FR)Université Sorbonne Paris Nord(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Saint-Louis(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Gastrointestinal Tumor Research and Treatment, Colorectal Cancer Surgical Treatments
Most-Cited Works
- → Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial(2021)1,199 cited
- → Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study(2008)691 cited
- → Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin(1999)495 cited
- → Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study(2022)357 cited
- → Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment(2013)323 cited